58 related articles for article (PubMed ID: 17558696)
1. Markers of apoptosis and proliferation related gene products as predictors of treatment outcome in childhood acute lymphoblastic leukemia.
Hafez M; Al-Tonbary Y; El-Bayoumi MA; Hatem N; Hawas S; Mansour A; Marzouk I; Hafez MM; Yahia S; Farahat N
Hematology; 2007 Jun; 12(3):209-18. PubMed ID: 17558696
[TBL] [Abstract][Full Text] [Related]
2. Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia.
Wuchter C; Karawajew L; Ruppert V; Schrappe M; Harbott J; Ratei R; Dörken B; Ludwig WD
Br J Haematol; 2000 Jul; 110(1):154-60. PubMed ID: 10930993
[TBL] [Abstract][Full Text] [Related]
3. Expression of apoptosis regulators Bcl-2 and Bax in childhood acute lymphoblastic leukemia.
Narayan S; Chandra J; Sharma M; Naithani R; Sharma S
Hematology; 2007 Feb; 12(1):39-43. PubMed ID: 17364991
[TBL] [Abstract][Full Text] [Related]
4. Low mRNA expression of the apoptosis-related genes CASP3, CASP8, and FAS is associated with low induction treatment response in childhood acute lymphoblastic leukemia (ALL).
Mata JF; Silveira VS; Mateo EC; Cortez MA; Queiroz RG; Yunes JA; Lee ML; Toledo SR; Petrilli AS; Brandalise SR; Tone LG; Scrideli CA
Pediatr Blood Cancer; 2010 Jul; 55(1):100-7. PubMed ID: 20232432
[TBL] [Abstract][Full Text] [Related]
5. Significance of SODD expression in childhood acute lymphoblastic leukemia and its influence on chemotherapy.
Tao HF; Liu YS; Fang JL; Su YZ; Chen FH; Zhou LY; Zhu YS
Genet Mol Res; 2014 Mar; 13(1):2020-31. PubMed ID: 24737427
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of CD95, Active Caspase-3, and Bcl-2 Expression in Adult Patients with De Novo Acute Lymphoblastic Leukemia.
Montiel-Cervantes LA; Reyes-Maldonado E; Garcia-Chavez J; Hernandez-Caballero A; Molina-Aguilar R; Garcia-Ruiz Esparza MA; Vela-Ojeda J
Arch Med Res; 2018 Jan; 49(1):44-50. PubMed ID: 29680307
[TBL] [Abstract][Full Text] [Related]
7. Significantly increased CD70 up regulation on TEL-AML positive B cell precursor acute lymphoblastic leukemia cells following CD40 stimulation.
Troeger A; Glouchkova L; Ackermann B; Escherich G; Hanenberg H; Janka G; Roettgers S; Göbel U; Dilloo D
Klin Padiatr; 2014 Nov; 226(6-7):332-7. PubMed ID: 25062112
[TBL] [Abstract][Full Text] [Related]
8. Src, Akt, NF-κB, BCL-2 and c-IAP1 may be involved in an anti-apoptotic effect in patients with BCR-ABL positive and BCR-ABL negative acute lymphoblastic leukemia.
Vázquez-Franco JE; Reyes-Maldonado E; Vela-Ojeda J; Domínguez-López ML; Lezama RA
Leuk Res; 2012 Jul; 36(7):862-7. PubMed ID: 22591684
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of tumor suppressor genes and their association with chimeric oncogenes in pediatric acute lymphoblastic leukemia.
Kustanovich AM; Savitskaja TV; Bydanov OI; Belevtsev MV; Potapnev MP
Leuk Res; 2005 Nov; 29(11):1271-6. PubMed ID: 15878620
[TBL] [Abstract][Full Text] [Related]
10. Synergistic activity of bortezomib and HDACi in preclinical models of B-cell precursor acute lymphoblastic leukemia via modulation of p53, PI3K/AKT, and NF-κB.
Bastian L; Hof J; Pfau M; Fichtner I; Eckert C; Henze G; Prada J; von Stackelberg A; Seeger K; Shalapour S
Clin Cancer Res; 2013 Mar; 19(6):1445-57. PubMed ID: 23357978
[TBL] [Abstract][Full Text] [Related]
11. Monitoring treatment response of childhood acute lymphocytic leukemia with certain molecular and biochemical markers.
Barakat M; Elkhayat Z; Kholoussi N; Elnady H; Ismail M; Raafat J
J Biochem Mol Toxicol; 2010; 24(6):343-50. PubMed ID: 21182165
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of microRNA-143 inhibits growth and induces apoptosis in human leukemia cells.
Shen JZ; Zhang YY; Fu HY; Wu DS; Zhou HR
Oncol Rep; 2014 May; 31(5):2035-42. PubMed ID: 24626955
[TBL] [Abstract][Full Text] [Related]
13. CD40 stimulation induces differentiation of acute lymphoblastic leukemia cells into dendritic cells.
Luczyński W; Stasiak-Barmuta A; Iłendo E; Krawczuk-Rybak M; Malinowska I; Mitura-Lesiuk M; Parfieńczyk A; Szymański M
Acta Biochim Pol; 2006; 53(2):377-82. PubMed ID: 16733557
[TBL] [Abstract][Full Text] [Related]
14. Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry.
Thörn I; Forestier E; Botling J; Thuresson B; Wasslavik C; Björklund E; Li A; Lindström-Eriksson E; Malec M; Grönlund E; Torikka K; Heldrup J; Abrahamsson J; Behrendtz M; Söderhäll S; Jacobsson S; Olofsson T; Porwit A; Lönnerholm G; Rosenquist R; Sundström C
Br J Haematol; 2011 Mar; 152(6):743-53. PubMed ID: 21250970
[TBL] [Abstract][Full Text] [Related]
15. Prognostic cytogenetic markers in childhood acute lymphoblastic leukemia: cases from Mansoura, Egypt.
Settin A; Al Haggar M; Al Dosoky T; Al Baz R; Abdelrazik N; Fouda M; Aref S; Al-Tonbary Y
Hematology; 2006 Oct; 11(5):341-9. PubMed ID: 17607584
[TBL] [Abstract][Full Text] [Related]
16. EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia.
Konantz M; André MC; Ebinger M; Grauer M; Wang H; Grzywna S; Rothfuss OC; Lehle S; Kustikova OS; Salih HR; Handgretinger R; Fend F; Baum C; Kanz L; Quintanilla-Martinez L; Schulze-Osthoff K; Essmann F; Lengerke C
Leukemia; 2013 Jan; 27(1):56-65. PubMed ID: 22828445
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.
Cavé H; van der Werff ten Bosch J; Suciu S; Guidal C; Waterkeyn C; Otten J; Bakkus M; Thielemans K; Grandchamp B; Vilmer E
N Engl J Med; 1998 Aug; 339(9):591-8. PubMed ID: 9718378
[TBL] [Abstract][Full Text] [Related]
18. mRNA expression of apoptosis-associated genes in infant acute lymphoblastic leukemia: low Fas expression is an independent predictor for poor prognosis.
Suminoe A; Matsuzaki A; Hattori H; Koga Y; Kinukawa N; Ishii E; Hara T
Leukemia; 2004 Feb; 18(2):365-8. PubMed ID: 14647399
[No Abstract] [Full Text] [Related]
19. Reduced expression and defective modulation of TNF receptor/ligand family molecules on proB-ALL blasts.
Troeger A; Glouchkova L; Escherich G; Siepermann M; Hanenberg H; Janka-Schaub G; Göbel U; Ackermann B; Dilloo D
Klin Padiatr; 2008; 220(6):353-7. PubMed ID: 18949670
[TBL] [Abstract][Full Text] [Related]
20. Proliferation and apoptosis in newly diagnosed and relapsed childhood acute lymphoblastic leukemia.
Volm M; Zintl F; Sauerbrey A; Koomägi R
Anticancer Res; 1999; 19(5B):4327-31. PubMed ID: 10628395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
